IKCEST

AstraZeneca COVID-19 vaccine shows average efficiency of 70%

Nov 23, 2020

Source: https://news.cgtn.com/news/2020-11-23/AstraZeneca-COVID-19-vaccine-shows-average-efficiency-of-70--VEuqZFXmcE/index.html

It takes around min to read this article.

AstraZeneca said on Monday its vaccine for the novel coronavirus, developed along with the University of Oxford, has shown an average efficiency of 70 percent in protecting against the virus in two study segments.

"This vaccine's efficacy and safety confirm that it will be highly effective against COVID-19 and will have an immediate impact on this public health emergency," AstraZeneca chief executive Pascal Soriot said in a statement.

The results ranged between 62- and 90-percent efficacy depending on the vaccine dosage.

The announcement comes after other trials of vaccines developed by Pfizer/BioNTech and Moderna announced effectiveness above 90 percent.

(With input from Reuters, AFP)

Original Text (This is the original text for your reference.)

The results ranged between 62- and 90-percent efficacy depending on the vaccine dosage.

The announcement comes after other trials of vaccines developed by Pfizer/BioNTech and Moderna announced effectiveness above 90 percent.

(With input from Reuters, AFP)

Comments

Something to say?

Disclaimer: The translated content is provided by third-party translation service providers, and IKCEST shall not assume any responsibility for the accuracy and legality of the content.